Xiaodong Ren

2.3k total citations
73 papers, 1.8k citations indexed

About

Xiaodong Ren is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaodong Ren has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Xiaodong Ren's work include Cancer Genomics and Diagnostics (6 papers), Computational Drug Discovery Methods (4 papers) and Peptidase Inhibition and Analysis (4 papers). Xiaodong Ren is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Computational Drug Discovery Methods (4 papers) and Peptidase Inhibition and Analysis (4 papers). Xiaodong Ren collaborates with scholars based in China, United States and United Kingdom. Xiaodong Ren's co-authors include Chengyuan Liang, Lei Tian, Rui Zeng, Minyi Jia, Yan Qu, Wenqiang Cao, Hong Liu, Katherine G. Maffucci, Nancy C. Kupina and Rathna Nath and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Langmuir.

In The Last Decade

Xiaodong Ren

69 papers receiving 1.8k citations

Peers

Xiaodong Ren
Xue Lei China
Hibah M. Aldawsari Saudi Arabia
Terry Riss United States
Aysun Adan Türkiye
Rui Xu China
Xiaodong Ren
Citations per year, relative to Xiaodong Ren Xiaodong Ren (= 1×) peers Xiangqian Kong

Countries citing papers authored by Xiaodong Ren

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Ren more than expected).

Fields of papers citing papers by Xiaodong Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Ren. The network helps show where Xiaodong Ren may publish in the future.

Co-authorship network of co-authors of Xiaodong Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Ren. A scholar is included among the top collaborators of Xiaodong Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Ren. Xiaodong Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Xiaodong, et al.. (2025). Effects of information framing cues and age on the comprehension of personal health records for self-care behaviors: an eye-tracking study. Journal of the American Medical Informatics Association. 32(7). 1174–1185.
2.
Gui, Huan, et al.. (2024). Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer. International Journal of Nanomedicine. Volume 19. 3589–3605. 17 indexed citations
3.
Yang, Jun, Yan Yu, Xiaodong Ren, et al.. (2024). 59O A first-in-human, phase I study of BPI-371153, a novel small-molecule PD-L1 inhibitor, in advanced solid tumors or recurrent/refractory (r/r) lymphoma. Annals of Oncology. 35. S1427–S1427. 1 indexed citations
4.
Ren, Xiaodong, Yuwei Li, Jin Li, et al.. (2023). Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2. iScience. 26(3). 106245–106245. 16 indexed citations
5.
Zhang, Jie, Lei Tian, Liang Xin, et al.. (2023). A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects. Molecules. 28(4). 1762–1762. 44 indexed citations
6.
Li, Jin, Shaoli Deng, Min Li, et al.. (2023). Development of a novel integrated isothermal amplification system for detection of bacteria-spiked blood samples. AMB Express. 13(1). 135–135. 1 indexed citations
7.
Ren, Xiaodong, Ning Su, Shaoli Deng, et al.. (2023). Rapid detection of EGFR mutation in CTCs based on a double spiral microfluidic chip and the real-time RPA method. Analytical and Bioanalytical Chemistry. 415(17). 3535–3547. 4 indexed citations
8.
Ren, Xiaodong, et al.. (2023). Isothermal exponential amplification reactions triggered by circular templates (cEXPAR) targeting miRNA. Molecular Biology Reports. 50(4). 3653–3659. 6 indexed citations
9.
Liang, Chengyuan, Yuzhi Liu, Juan Li, et al.. (2021). Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic. Phytomedicine Plus. 1(2). 100027–100027. 27 indexed citations
10.
Tian, Lei, Chengyuan Liang, Xiaodong Ren, et al.. (2021). RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic. European Journal of Medicinal Chemistry. 213. 113201–113201. 154 indexed citations
12.
Niu, Yali, Jing Zhang, Shu Zhang, et al.. (2021). Aerobic exercise improves VCI through circRIMS2/miR-186/BDNF-mediated neuronal apoptosis. Molecular Medicine. 27(1). 4–4. 26 indexed citations
13.
Ren, Xiaodong, et al.. (2020). Urine cell‐free DNA as a promising biomarker for early detection of non‐small cell lung cancer. Journal of Clinical Laboratory Analysis. 34(8). e23321–e23321. 17 indexed citations
15.
Liu, Yuzhi, Chengyuan Liang, Liang Xin, et al.. (2020). The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020. European Journal of Medicinal Chemistry. 206. 112711–112711. 125 indexed citations
16.
Su, Ning, Kun Wei, Na Zhao, et al.. (2019). Sensitive and selective detections of codon 12 and 13 KRAS mutations in a single tube using modified wild-type blocker. Clinica Chimica Acta. 494. 123–131. 3 indexed citations
17.
Li, Ying, Xiaodong Ren, Hao Luo, et al.. (2019). Preparation and evaluation of Bletilla striata polysaccharide/graphene oxide composite hemostatic sponge. International Journal of Biological Macromolecules. 130. 827–835. 67 indexed citations
18.
Liang, Chengyuan, et al.. (2018). The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review. European Journal of Medicinal Chemistry. 151. 315–326. 137 indexed citations
19.
Song, Yi, et al.. (2017). In vivo wound healing and in vitro antioxidant activities of Bletilla striata phenolic extracts. Biomedicine & Pharmacotherapy. 93. 451–461. 80 indexed citations
20.
Wei, Feng, et al.. (2007). Efficient antiproliferative and antiangiogenic effects on human ovarian cancer growth by gene transfer of attenuated mutants of Shiga-like toxin I. International Journal of Gynecological Cancer. 18(4). 677–691. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026